Key Highlights
- Strategic collaboration between SimBioSys and Mayo Clinic to advance digital precision medicine solutions, focusing on individualized care for breast cancer patients.
- Development of TumorSightTM, a cloud-based clinical software tool utilizing AI for detailed 3D tumor modeling, aiding in surgical planning and treatment strategies.
- Mayo Clinic’s Comprehensive Cancer Center involvement and support, leveraging their extensive research and clinical trial data to enhance SimBioSys’s platform capabilities.
Source: Business Wire
Notable Quote
- “SimBioSys complements current precision medicine techniques while only relying on readily available and previously acquired datasets such as imaging. We are delighted to collaborate with Mayo Clinic as we bring our innovative technology to patients.” – Tushar Pandey, co-founder and CEO at SimBioSys
SoH's Take
This collaboration signifies a substantial stride towards personalizing breast cancer treatment. By leveraging the combined expertise of SimBioSys’s AI and spatial biophysics and Mayo Clinic’s comprehensive cancer care and clinical data, the partnership is poised to develop groundbreaking solutions that offer a more nuanced and effective approach to treatment planning and decision-making. As the medical community continues to recognize the importance of tailored treatment plans, this alliance is timely and holds great promise for enhancing patient outcomes and quality of life in the battle against breast cancer. With the potential to revolutionize surgical planning and risk stratification, this collaboration marks an exciting step forward in the convergence of technology and healthcare.
